✦ LIBER ✦

Evaluation of a continuous combined low-dose regimen of estrogen-progestin for treatment of the menopausal patient

✍ Scribed by L Weinstein; C Bewtra; JC Gallagher

Book ID: 118890577
Publisher: Elsevier Science
Year: 1991
Tongue: English
Weight: 276 KB
Volume: 34
Category: Article
ISSN: 0020-7292
DOI: 10.1016/0020-7292(91)90651-k

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Continuous Combined Hormone Re

Long-Term Continuous Combined Hormone Replacement Therapy in the Prevention of Postmenopausal Bone Loss: A Comparison of High- and Low-Dose Estrogen–Progestin Regimens

✍ J. Heikkinen; R. Vaheri; P. Kainulainen; U. Timonen 📂 Article 📅 2000 🏛 Springer-Verlag 🌐 English ⚖ 155 KB

Continuous-combined treatment of the men

Continuous-combined treatment of the menopause with combinations of oestradiol valerate and dienogest — a dose-ranging study

✍ T Gräser; A Müller; U Mellinger; A.O Mück; T.H Lippert; M Oettel 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Evaluation of the bioavailability and do

Evaluation of the bioavailability and dose proportionality of three formulations of a combination estrogen and progestin adhesive-based matrix transdermal delivery system

✍ Helen S. Pentikis; Mary Ellen Mullin; Michael Howard; Bruno Boutouyrie; Gerald R 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 777 KB

Pilot study of continuous low-dose 5-flu

Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer

✍ Y. Yamada; K. Aiba; N. Horikosi; M. Hanai; S. Uno; H. Osawa; N. Mizunuma; S. Tak 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 59 KB

Evaluation of continuous infusion low-do

Evaluation of continuous infusion low-dose 5-azacytidine in the treatment of myelodysplastic syndromes

✍ Dr. Christopher R. Chitambar; Joseph A. Libnoch; William G. Matthaeus; Robert C. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB 👁 2 views

Evaluation of the long-term safety of a

Evaluation of the long-term safety of a 91-day extended regimen oral contraceptive with low-dose estrogen in place of placebo

✍ Matthew Davis; Kathleen Z. Reape; Howard Hait 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 64 KB